跳至主要内容
临床试验/NCT02135146
NCT02135146已完成4 期

Evaluating Fluid Strategies in Thoracic Surgery Patients Utilizing a Goal Directed Approach

University of Colorado, Denver1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
40
试验地点
1
主要终点
Development of Renal Injury

研究概览

简要总结

The purpose of this study is to conduct a prospective, randomized, controlled trial comparing a restrictive vs. conservative fluid strategy in thoracic surgery patients. Excessive perioperative fluid has been retrospectively implicated in the development postoperative acute lung injury (PALI) and pulmonary edema following lung resection. However, fluid restriction in these patients is not without risk and may compromise end organ perfusion (i.e. acute kidney injury). The hypothesis is that a conservative fluid approach in thoracic surgery patients will result in better end organ perfusion with fewer occasions of acute kidney injury (AKI) without causing an increase in postoperative acute lung injury or pulmonary edema.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • between 18-89 years of age
  • undergoing pulmonary lobectomy with open or video assisted thoracotomy

排除标准

  • patient refusal
  • pregnancy
  • cardiac arrhythmia
  • pacemaker dependency
  • severe aortic insufficiency
  • idiopathic hypertrophic subaortic stenosis
  • prisoners
  • decisionally challenged
  • patients that refuse to receive intravenous fluid products made from human plasma (Albumin 5%)
  • patients with skin infection or breakdown on their fingers
  • severe peripheral vascular disease
  • evidence of compromised finger perfusion will be excluded

研究组 & 干预措施

Plasmalyte 3ml/kg/hr group

Active Comparator

干预措施: Plasmalyte 3ml/kg/hr group (Drug)

Plasmalyte 6ml/kg/hr group

Active Comparator

干预措施: Plasmalyte 6ml/kg/hr group (Drug)

结局指标

主要结局

Development of Renal Injury

时间窗: Post-op up to 72 hours

Acute renal injury as defined by the American Kidney Injury Network (AKIN) criteria in the first 72 hours postoperatively (serum creatinine levels). The AKIN scale will be used to assess the presence and severity of acute kidney injury (AKI). The AKIN is a classification/staging system of acute kidney injury developed by the Acute Kidney Injury Network which uses changes in serum creatinine (SCr) and urine output to assess AKI. Stages of acute kidney injury are defined as 1, 2, or 3, with 3 indicating the most severe AKI. (1) Increase ≥ 0.3 mg per dL (26.52 μmol per L) or ≥ 1.5- to twofold from baseline. (2) Increase \> two- to threefold from baseline. (3) Increase \> threefold from baseline or ≥ 4.0 mg per dL (353.60 μmol per L) with an acute rise of at least 0.5 mg per dL (44.20 μmol per L).

Development of Pulmonary Edema

时间窗: Post-op up to 72 hours

The number of participants diagnosed with mild to severe pulmonary edema at any time up to 72 hours after surgery is reported.

次要结局

  • Death(Assessed up to 30 days Post-op)
  • Development of Morbidity(Up to 7 days)
  • Length of Surgical Intensive Unit Stay/Hospital Stay(Up to 7 days)
  • Removal of Chest Tubes(Post-op up to 48 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验